The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cremophor EL-free formulation of paclitaxel: A randomized, multicenter, safety, and efficacy study of nanosomal paclitaxel lipid suspension (NPLS) versus paclitaxel in women with metastatic breast cancer (MBC).
Ateeq Ahmad
Employment or Leadership Position - Jina Pharmaceuticals
Saifuddin Sheikh
Employment or Leadership Position - Jina Pharmaceuticals
Ajay O. Mehta
No relevant relationships to disclose
Rajnish Vasant Nagarkar
No relevant relationships to disclose
Krishnan Srinivasan
No relevant relationships to disclose
Anup Majumdar
No relevant relationships to disclose
Kalyan Kusum Mukherjee
No relevant relationships to disclose
Jitendra K Singh
No relevant relationships to disclose
SP Shrivastav
No relevant relationships to disclose
C T. Satheesh
No relevant relationships to disclose
Tanveer Maksud
No relevant relationships to disclose
Suraj Pawar
No relevant relationships to disclose
Satish Ramkrishna Sonawane
No relevant relationships to disclose
Satish V Kamat
No relevant relationships to disclose
Manish Sharma
Employment or Leadership Position - Lambda Therapeutic Research
R. C. Rane
Employment or Leadership Position - Intas
Imran Ahmad
Employment or Leadership Position - Jina Pharmaceuticals